| Filed | Description | |
|---|---|---|
| 7/16/25 | 1.02 Agreement Terminated | → |
| 6/13/25 | 1.02 Agreement Terminated | → |
| 10/17/24 | 1.01 Material Agreement | → |
| 7/23/24 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 10/12/23 | 1.01 Material Agreement | → |
| 10/6/23 | 1.01 Material Agreement | → |
| ↓ 21 more | ||
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.